心脏移植患者心肌细胞外容积分数与T2-mapping的预后价值
本研究纳入99例心脏移植患者,行心脏MRI T1-mapping(n=90)和T2-mapping(n=79),随访2.4至3.5年。结果显示ECV>29%与T2≥50.2 ms分别独立预测不良临床结局,提示MRI心肌组织特征参数具有预后价值,作者指出需更大规模前瞻性研究。
要点
- 心脏移植患者ECV>29%独立预测不良临床结局(HR 2.87),T2≥50.2 ms独立预测不良结局(HR 3.01)。
- T2≥50.2 ms还独立预测心脏事件(HR 4.92)。
- MRI-derived ECV和T2 mapping与心脏及非心脏结局独立相关。
关键影像表现/征象
- 整体native T1为1,030 ± 56 ms,postcontrast T1为458 ± 84 ms,ECV为27 ± 4%,T2为50 ± 4 ms。
诊断标准与关键数值
- ECV最高三分位范围(ECV>29%)与最低三分位范围(ECV<25%)相比,独立预测不良临床结局(HR 2.87;95%CI 1.07至7.68;p=0.04),模型纳入左心室收缩末期容积和LGE。
- 较高T2(T2≥50.2 ms)独立预测不良临床结局(HR 3.01;95%CI 1.39至6.54;p=0.005),校正左心室射血分数、左心室收缩末期容积和LGE。
- 较高T2(T2≥50.2 ms)还独立预测心脏事件(HR 4.92;95%CI 1.60至15.14;p=0.005),模型纳入左心室射血分数。
局限性
- 作者指出需更大规模前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of this study was to examine prognostic value of T1- and T2-mapping techniques in heart transplant patients.
BACKGROUND: Myocardial characterization using T2 mapping (evaluation of edema/inflammation) and pre- and post-gadolinium contrast T1 mapping (calculation of extracellular volume fraction [ECV] for assessment of interstitial expansion/fibrosis) are emerging modalities that have been investigated in various cardiomyopathies.
METHODS: A total of 99 heart transplant patients underwent the magnetic resonance imaging (MRI) scans including T1- (n = 90) and T2-mapping (n = 79) techniques. Relevant clinical characteristics, MRI parameters including late gadolinium enhancement (LGE), and invasive hemodynamics were collected. Median clinical follow-up duration after the baseline scan was 2.4 to 3.5 years. Clinical outcomes include cardiac events (cardiac death, myocardial infarction, coronary revascularization, and heart failure hospitalization), noncardiac death and noncardiac hospitalization.
RESULTS: Overall, the global native T1, postcontrast T1, ECV, and T2 were 1,030 ± 56 ms, 458 ± 84 ms, 27 ± 4% and 50 ± 4 ms, respectively. Top-tercile-range ECV (ECV >29%) independently predicted adverse clinical outcomes compared with bottom-tercile-range ECV (ECV <25%) (hazard ratio [HR]: 2.87; 95% confidence interval [CI]: 1.07 to 7.68; p = 0.04) in a multivariable model with left ventricular end-systolic volume and LGE. Higher T2 (T2 ≥50.2 ms) independently predicted adverse clinical outcomes (HR: 3.01; 95% CI: 1.39 to 6.54; p = 0.005) after adjustment for left ventricular ejection fraction, left ventricular end-systolic volume, and LGE. Additionally, higher T2 (T2 ≥50.2 ms) also independently predicted cardiac events (HR: 4.92; CI: 1.60 to 15.14; p = 0.005) in a multivariable model with left ventricular ejection fraction.
CONCLUSIONS: MRI-derived myocardial ECV and T2 mapping in heart transplant patients were independently associated with cardiac and noncardiac outcomes. Our findings highlight the need for larger prospective studies.
引用
- Chaikriangkrai K, Abbasi MA, Sarnari R, et al. Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients. JACC Cardiovasc Imaging. 2020. PMID: 32199848. doi:10.1016/j.jcmg.2020.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。